The incidence of resistance to erythromycin in populations of staphylococci represents a potential problem in hospitals and outpatient facilities where the antibiotic is widely used. The problem was recognized soon after erythromycin was introduced (5) . Cross-resistance between erythromycin and other macrolides is considerable, but not complete: erythromycin-resistant hospital strains are not necessarily resistant to spiramycin or oleandomycin (4) , whereas almost complete cross-resistance can be observed in in vitro experiments (6) .
"Dissociated" resistance as a phenomenon was first described by Chabbert (1) and has received considerable attention from several investigators. It is readily demonstrated with several macrolide antibiotics. The process involves an induction of resistance to one antibiotic, e.g., erythromycin, and at the same time resistance to another, e.g., spiramycin, to which the strain was originally susceptible and which is not itself an inducer.
In biochemical terms it has been postulated that erythromycin acts simultaneously at two sites in the cell and exerts two different types of effects (21) . One is a specific binding to a regulator of expression of a structural gene governing macrolide resistance, whereas the other effect involves interaction with a specific site at the 50S ribosomal subunit during translocation (20) . As to the former effect, Weisblum and his coworkers showed in a series of contributions (21, 22) that the presence of an adenine-N6-methyltransferase is essential for the manifestation of resistance. Resistant phenotypes are optimally induced at 10 to 100 nM concentrations of erythromycin. Above 100 nM the inhibitory effect becomes more pronounced by inhibiting the translation of all messenger ribonucleic acids, including those which might have been synthesized as a result of induction (22) .
Elsewhere, attempts have been made to identify structural determinants for induction by testing a variety of erythromycin derivatives and degradation products in vitro in staphylococcal strains with inducible drug resistance (16, 19) .
Erythromycin metabolites of human origin have apparently never been examined for inducer activity. Since it can be assumed that they persist in the circulation for prolonged periods (18) out delay. To each urine sample was added an equal volume of 10% aqueous zinc sulfate solution, and the mixture was adjusted to pH 9.5 with NaOH (15% aqueous). The gelatinous precipitate was removed by filtration, and the filtrate was extracted four times with CHC13. The combined chloroform extracts containing the erythromycin bases and the neutral compounds were washed with water, dried over anhydrous Na2SO4, and evaporated to dryness.
Column chromatography. The crude residue (250 mg) was applied in a small volume of CHC13 to the top of a Sephadex LH-20 column (2.0 by 120 cm; bed volume, 300 ml) equilibrated in chloroform-hexane (1:1) (10). Fractions of 5 ml were collected at a flow rate of 0.1 nil/cm2 per mi and monitored by thinlayer chromatography. Erythromycin was eluted at 0.9 to 1.0 column volumes, and its 8,9-anhydro-6,9-hemiketal (Met 1) was eluted at 1.4 to 1.5 column volumes. The metabolites designated Met 5 and Met 8 were eluted at 2.5 and 4.4 column volumes, respectively.
Thin-layer chromatography. The individual fractions from column chromatography were examined on thin-layer plates coated with Silica Gel F-254 (layer thickness, 0.25 mm; E.M. Laboratories, Inc., Elmsford, N.Y.). The solvent system consisted of ethyl acetate-isopropanol-ammonium acetate (15% [wt/vol] aqueous, adjusted to pH 9.6), 9:7:8 (upper phase) (12) . Detection was done by spraying the plates with anisaldehyde-concentrated H2SO4-ethanol, 1:1:9 (vol/vol); gray-blue colors developed after a few minutes at 800C.
Antibiotics. Erythromycin was a gift from Abbott Laboratories, North Chicago, Ill.; erythromycin SensiDiscs were from BBL Microbiology Systems, Cockeysville, Md. Carbomycin was obtained by the courtesy of Pfizer Inc., Groton, Conn. Methymycin, pikromycin, and a nonmacrolide antibiotic, designated NN, were produced by fermentation in my laboratory.
Metabolites. The three metabolites of erythromycin studied in this paper were isolated from urine samples of patients treated for infection with erythromycin (for an example ofa case history, see reference 11). They were arbitrarily designated Met 1, Met 5, and Met 8. Met 1 was shown to be the 8,9-anhydro-6,9-erythromycin A hemiketal (erythromycin A-8,9-enol ether) by chromatography, spectra, and comparison with an authentic sample (8). Met 5 was tentatively assigned as a 4,5-anhydro-6,9;9,12-spiroketal of erythronolide A (mass spectrometry displayed a parent ion at an mie of 402). The structure of Met 8 has been shown to be the propionamide of the didemethylated 6,9;9,12-spiroketal of erythromycin A and has been reported previously (11) .
Induction of resistance on solid culture media.
The method for examining inducer activity was similar to that described by Weisblum et al. (22) . Paper disks with selected antibiotics and metabolites and controls (plain paper disks) were placed on a lawn of the inducible test strain in soft agar (0.5%) along with disks containing carbomycin. When paired with a control or with a noninducer, carbomycin formed a regular zone of inhibition. If the other disk contained a compound with inducer activity, the inhibitory zone surrounding the carbomycin disk became distorted (see Fig. 1 Figure 1 shows the experimental arrangement in which S. aureus RN 1389 was tested with five antibiotics, four of which were macrolides: carbomycin (7), erythromycin (23), pikromycin (14, 17) , and methymycin (2). The fifth antibiotic Regular inhibition zones were seen in the presence of a control paper disk and with methymycin, which did not seem to produce any effect. Pikromycin and the nonmacrolide antibiotic NN were inhibitory to the test strain without visibly affecting the inhibitory action of carbomycin. A different picture was obtained with erythromycin; it distorted the zone of inhibition due to carbomycin. It can also be noted that in the immediate proximity of the disk, the effect of erythromycin was inhibitory due to its high initial concentration. Figure 2 depicts an arrangement with metabolites of ERM isolated from urine of a patient. Clockwise, always paired with a disk containing carbomycin, were a control disk, an erythromycin disk, and disks containing the three metabolites of erythromycin. Although Met 5 and Met 8 did not seem to have any effect, Met 1 exhibited an effect similar to that of erythromycin in distorting the inhibition zone due to carbomycin.
The effect of Met 1 appeared to be unchanged over a wide range of concentrations (Fig. 3) . The range of concentrations, i.e., 20 This indicates that the metabolite itself was not inhibitory, even at a concentration 13 times higher than that of erythromycin, and also that there was no contamination with erythromycin. A complementary arrangement to that in Fig. 3 , displaying a different pattern, is shown in Fig. 4 . Erythromycin, in concentrations corresponding to those of Met 1 in Fig. 3, i .e., 200, 100, and 20 ,ug, exhibited both inducer and inhibitory effects, whereas the action of Met 1 was consistently the same.
The inducer effect of Met 1 on the strain in liquid medium was demonstrated (Fig. 5) . Met 1, when added at zero time of incubation, eliminated the inhibitory effect of erythromycin which was added 2 h later. Without the inducer, the growth of the control culture became substantially reduced upon the addition of erythromycin.
DISCUSSION
Although the data obtained allow a conclusion that a metabolite of an antimicrobial drug can indeed induce resistance to the parent drug in vitro, many other aspects of this phenomenon remain to be clarified. For instance, only 5 to 10% of the administered dose of erythromycin is excreted via the kidneys, and as to the qualitative and quantitative compositions, the metabolites excreted in urine may differ from those which are reabsorbed by the tubular system. The latter metabolites, individually or in a concerted manner, may be instrumental in the process of induction of resistance in vivo. Furthermore, the composition of the metabolites in circulation may be changed due to metabolic idio- syncrasies and also due to the underlying disease.
Erythromycin derivatives, various degradation products, and biosynthetic intermediates have been examined in in vitro studies in attempts to identify the roles of typical groups in their structures in the process of induction of resistance (16, 19) . In context with those studies, our data seem to corroborate one of the findings, that the free C-9 carbonyl group is not essential for resistance induction (19) , in contrast to its significance in the inhibition of protein synthesis. However, the inducer activity reported for the neutral compounds, i.e., erythronolide B and 3'-de-(dimethylamino)-erythromycin B, was not found in the case of our neutral metabolites, i.e., Met 5 and Met 8. In addition, in experiments not described here, erythronolide A (9), the aglycone of erythromycin A, was found to be inactive as an inducer under a comparable experimental arrangement. (Erythronolide A was obtained through the courtesy of W. A. Scott, HoffmannLa Roche, Inc., Nutley, N. J.).
Met 8, a neutral diglycoside, had no inducer activity in our experimental model. One of the limiting parameters may be its much higher polarity. On column chromatography, it was eluted at a column volume four times larger than that for erythromycin.
The demonstrated effectiveness of Met 1 as an inducer of resistance is not accompanied by antimicrobial activity. This may be due to the "elimination" of the C-9 carbonyl function, whereas the concomitant formation of the 6,9-enol ether in Met 1 does not imply any substantial changes in the overall conformation of the lactone moiety. In more precise terms, the intact lactone is endowed with a high degree of conformational stability stemming from the minimnized syn-periplanar interactions of the C-4 and C-6 methyl groups (13) and the ensuing intramolecular hydrogen bonding (15) . However, some conformational transitions can be induced in the flexible regions which include the lactone ring carbon atoms C-2 through C-5 and C-6 through C-9. The latter region has been shown to exist in an equilibrium of two limiting conformations. Relevant to our discussion is the partially eclipsed conformner with an "outward" positioning of C-7 which causes the dihedral angles between H-7a and H-8 and between H-7e and H-8 to attain values of nearly 120 and 00, respectively (3). In connection with the acid-catalyzed fornation of 8,9-enol ether via the 6,9-hemiketal, this appears to be the favored conformation. At the site of induction, the partially eclipsed conformer of erythromycin, and Met 1, may thus become indistinguishable (Fig. 6) . Occurrence of Met 1 as a product of acid catalysis (Fig. 7) is not unexpected. The intrinsic susceptibility of the erythromycin A molecule to acids is well known from chemical studies (23) , and exposure to acidic conditions in a patient cannot be prevented, e.g., sequestering of the free base from the circulation into the stomach (J. Majer, C. Raya, and J. W. Corcoran, Program Abstr. Intersci, Conf. Antimicrob. Agents Chemother. 15th, Wshington, D.C., abstr no. 14, 1975) . Among the studies initiated in this direction, the 8,9-anhydroerythromycin A 6,9-hemiketal was prepared and characterized (8) . In contrast to the 8,9-anhydroerythromycin B 6,9- hemiketal, acid hydrolysis does not yield the original ketoalcohol, instead, the 6,9;9,12-erythromycin A spiroketal is obtained (8) . This finding argues against the possibility that in the VOL. 19, 1981 process of induction of resistance, the effect would be due to erythromycin as a product of the hydrolyzed metabolite.
To what extent these in vitro experiments, albeit conducted with genuine metabolites, can be extrapolated to in vivo conditions remains to be seen. However, the data presented further document the fact that there are no requirements of a "selection pressure" in the process of induction of resistance.
